Recapping a record-breaking 2025 Krakow HTA Symposium
We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…
Simona ColucciJuly 30, 2025
Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development
Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.
CertaraJuly 29, 2025
MIDD Strategies for Preclinical and Clinical Translation: A Collaboration Between Clinical Pharmacologists and Modeling Disciplines
Learn how clinical pharmacologists and modeling experts collaborate to improve preclinical-to-clinical translation.
CertaraJuly 29, 2025
Boosting Confidence in Drug Discovery with PBPK
Explore Simcyp Discovery Version 2 updates to boost early-stage drug development.
CertaraJuly 25, 2025
How Pharma Can Transition to Non-animal Studies for Investigational Drugs
Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…
CertaraJuly 25, 2025
Certara Talks: The role of MIDD in Increasing Pharmaceutical R&D Efficiency
0:05 Hello and welcome to another episode of Certara Talks. 0:07 I'm Doctor Suzanne Minton…
Danielle PillsburyJuly 25, 2025
